Influence of whole arm loss of chromosome 16q on gene expression patterns in oestrogen receptor-positive, invasive breast cancer

Journal of Pathology

Volumn 224, Issue 4, 2011, Pages 517-528

  Hungermann, Daniela ^a   Schmidt, Hartmut ^a   Natrajan, Rachel ^b   Tidow, Nicola ^a   Poos, Kathrin ^a   Reis Filho, Jorge S ^b   Brandt, Burkhard ^c   Buerger, Horst ^d,e   Korsching, Eberhard ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b Breakthrough Breast Cancer Research Centre   (United Kingdom)

^c UNIVERSITY OF HAMBURG   (Germany)

^d Institute of Pathology   (Germany)

^e UTRECHT UNIVERSITY   (Netherlands)

Author keywords

breast cancer; chromosome 16q; global gene expression

Indexed keywords

ESTROGEN RECEPTOR;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER INVASION; CHROMOSOMAL INSTABILITY; CHROMOSOME 16Q; CHROMOSOME ARM; CHROMOSOME LOSS; CLINICAL ARTICLE; GENE DOSAGE; GENE EXPRESSION; GENE LOCATION; GENE LOSS; GENETIC ANALYSIS; GENOME; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 16; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79959970420     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2938     Document Type: Article

References (54)

1. Tirkkonen M, Tanner M, Karhu R, et al., Molecular cytogenetics of primary breast cancer by CGH. Genes Chromosomes Cancer 1998; 21: 177-184. (Pubitemid 28136434)
2. Tsuda H, Takarabe T, Fukutomi T, et al., der(16)t(1;16)/der(1;16) in breast cancer detected by fluorescence in situ hybridization is an indicator of better patient prognosis. Genes Chromosomes Cancer 1999; 24: 72-77. (Pubitemid 28544465)
3. Hislop RG, Pratt N, Stocks SC, et al., Karyotypic aberrations of chromosomes 16 and 17 are related to survival in patients with breast cancer. Br J Surg 2002; 89: 1581-1586. (Pubitemid 35404329)
4. Richard F, Pacyna GM, Schl, et al., Patterns of chromosomal imbalances in invasive breast cancer. Int J Cancer 2000; 89: 305-310. (Pubitemid 30430749)
5. Adeyinka A, Baldetorp B, Mertens F, et al., Comparative cytogenetic and DNA flow cytometric analysis of 242 primary breast carcinomas. Cancer Genet Cytogenet 2003; 147: 62-67. (Pubitemid 37324348)
6. Adeyinka A, Mertens F, Idvall I, et al., Different patterns of chromosomal imbalances in metastasising and non-metastasising primary breast carcinomas. Int J Cancer 1999; 84: 370-375. (Pubitemid 29337122)
7. Rennstam K, Ahlstedt-Soini M, Baldetorp B, et al., Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization. Cancer Res 2003; 63: 8861-8868. (Pubitemid 38064066)
8. Buerger H, Otterbach F, Simon R, et al., Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways. J Pathol 1999; 187: 396-402. (Pubitemid 29118269)
9. Vos CB, ter HN, Rosenberg C, et al., Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histologic type. Br J Cancer 2000; 81: 1410-1418.
10. Roylance R, Gorman P, Harris W, et al., Comparative genomic hybridization of breast tumours stratified by histological grade reveals new insights into the biological progression of breast cancer. Cancer Res 1999; 59: 1433-1436. (Pubitemid 29160105)
11. Natrajan R, Lambros MB, Geyer FC, et al., Loss of 16q in high grade breast cancer is associated with estrogen receptor status: evidence for progression in tumors with a luminal phenotype? Genes Chromosomes Cancer 2009; 48: 351-365.
12. O'Connell P, Pekkel V, Fuqua SA, et al., Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci. J Natl Cancer Inst 1998; 90: 697-703. (Pubitemid 28222144)
13. Cleton-Jansen AM, Buerger H, Haar NN, et al., Different mechanisms of chromosome 16 loss of heterozygosity in well versus poorly differentiated ductal breast cancer. Genes Chromosomes Cancer 2004; 41: 109-116. (Pubitemid 39096736)
14. Cleton-Jansen AM, Callen DF, Seshadri R, et al., Loss of heterozygosity mapping at chromosome arm 16q in 712 breast tumors reveals factors that influence delineation of candidate regions. Cancer Res 2001; 61: 1171-1177. (Pubitemid 32174440)
15. Kochetkova M, McKenzie OL, Bais AJ, et al., CBFA2T3 (MTG16) is a putative breast tumor suppressor gene from the breast cancer loss of heterozygosity region at 16q24.3. Cancer Res 2002; 62: 4599-4604.
16. Powell JA, Gardner AE, Bais AJ, et al., Sequencing, transcript identification, and quantitative gene expression profiling in the breast cancer loss of heterozygosity region 16q24.3 reveal three potential tumor-suppressor genes. Genomics 2002; 80: 303-310. (Pubitemid 34985020)
17. Kumar R, Neilsen PM, Crawford J, et al., FBXO31 is the chromosome 16q24.3 senescence gene, a candidate breast tumor suppressor, and a component of an SCF complex. Cancer Res 2005; 65: 11304-11313. (Pubitemid 41821687)
18. Buerger H, Mommers E, Littmann R, et al., Ductal invasive G2 and G3 carcinomas of the breast are the end stages of at least two different lines of genetic evolution. J Pathol 2001; 194: 165-170. (Pubitemid 32519965)
19. Lacroix-Triki M, Suarez PH, Mackay A, et al., Mucinous carcinoma of the breast is genomically distinct from invasive ductal carcinomas of no special type. J Pathol 2010; 222: 282-298.
20. Coe BP, Ylstra B, Carvalho B, et al., Resolving the resolution of array CGH. Genomics 2007; 89: 647-653. (Pubitemid 46589944)
21. Gunnarsson R, Staaf J, Jansson M, et al., Screening for copy-number alterations and loss of heterozygosity in chronic lymphocytic leukemia-a comparative study of four differently designed, high resolution microarray platforms. Genes Chromosomes Cancer 2008; 47: 697-711. (Pubitemid 351847582)
22. Tan DS, Lambros MB, Natrajan R, et al., Getting it right: designing microarray (and not 'microawry') comparative genomic hybridization studies for cancer research. Lab Invest 2007; 87: 737-754. (Pubitemid 47077258)
23. Geyer FC, Weigelt B, Natrajan R, et al., Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas. J Pathol 2010; 220: 562-573.
24. Mackay A, Tamber N, Fenwick K, et al., A high-resolution integrated analysis of genetic and expression profiles of breast cancer cell lines. Breast Cancer Res Treat 2009; 118: 481-498.
25. Natrajan R, Weigelt B, Mackay A, et al., An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancers. Breast Cancer Res Treat 2010; 121: 575-589.
26. Olshen AB, Venkatraman ES, Lucito R, et al., Circular binary segmentation for the analysis of array-based DNA copy number data. Biostatistics 2004; 5: 557-572. (Pubitemid 41180205)
27. Natrajan R, Lambros MB, Rodriguez-Pinilla SM, et al., Tiling path genomic profiling of grade 3 invasive ductal breast cancers. Clin Cancer Res 2009; 15: 2711-2722.
28. Korsching E, Packeisen J, Agelopoulos K, et al., Cytogenetic alterations and cytokeratin expression patterns in breast cancer: integrating a new model of breast differentiation into cytogenetic pathways of breast carcinogenesis. Lab Invest 2002; 82: 1525-1533. (Pubitemid 35332911)
29. Korsching E, Packeisen J, Helms MW, et al., Deciphering a subgroup of breast carcinomas with putative progression of grade during carcinogenesis revealed by comparative genomic hybridisation (CGH) and immunohistochemistry. Br J Cancer 2004; 90: 1422-1428. (Pubitemid 38586272)
30. Korsching E, Packeisen J, Liedtke C, et al., The origin of vimentin expression in invasive breast cancer: epithelial-mesenchymal transition, myoepithelial histogenesis or histogenesis from progenitor cells with bilinear differentiation potential? J Pathol 2005; 206: 451-457. (Pubitemid 41025348)
31. Marchio C, Lambros MB, Gugliotta P, et al., Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescence in situ hybridization and microarray-based CGH analysis. J Pathol 2009; 219: 16-24.
32. Agelopoulos K, Kersting C, Korsching E, et al., Egfr amplification specific gene expression in phyllodes tumours of the breast. Cell Oncol 2007; 29: 443-451. (Pubitemid 350136499)
33. Livak KJ, Schmittgen TD,. Analysis of relative gene expression data using real-time quantitative PCR and the method. Methods 2001; 25: 402-408. (Pubitemid 34164012)
34. Bolstad BM, Irizarry RA, Astrand M, et al., A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003; 19: 185-193. (Pubitemid 36181903)
35. Knowles HJ, Cleton-Jansen AM, Korsching E, et al., Hypoxia-inducible factor regulates osteoclast-mediated bone resorption: role of angiopoietin-like 4. FASEB J 2010; 24: 4648-4659.
36. Tusher VG, Tibshirani R, Chu G,. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001; 98: 5116-5121. (Pubitemid 32397092)
37. Korsching E, Agelopolous K, Schmidt H, et al., Improvements in the analysis strategy make single nucleotide polymorphism analysis a powerful tool in the detection and characterization of amplified chromosomal regions in human tumors. Pathobiology 2006; 73: 18-25. (Pubitemid 43952602)
38. Bombonati A, Sgroi DC,. The molecular pathology of breast cancer progression. J Pathol 2011; 223: 307-317.
39. Rakha EA, Green AR, Powe DG, et al., Chromosome 16 tumor-suppressor genes in breast cancer. Genes Chromosomes Cancer 2006; 45: 527-535. (Pubitemid 43727159)
40. Pollack JR, Sorlie T, Perou CM, et al., Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc Natl Acad Sci USA 2002; 99: 12963-12968.
41. Klebig C, Seitz S, Korsching E, et al., Profile of differentially expressed genes after transfer of chromosome 17 into the breast cancer cell line CAL51. Genes Chromosomes Cancer 2005; 44: 233-246. (Pubitemid 41397092)
42. Nordgard SH, Johansen FE, Alnaes GI, et al., Genome-wide analysis identifies 16q deletion associated with survival, molecular subtypes, mRNA expression, and germline haplotypes in breast cancer patients. Genes Chromosomes Cancer 2008; 47: 680-696. (Pubitemid 351847581)
43. Wennmalm K, Calza S, Ploner A, et al., Gene expression in 16q is associated with survival and differs between Sorlie breast cancer subtypes. Genes Chromosomes Cancer 2007; 46: 87-97. (Pubitemid 44772875)
44. Ito S, Tan LJ, Andoh D, et al., MMXD, a TFIIH-independent XPD-MMS19 protein complex involved in chromosome segregation. Mol Cell 2010; 39: 632-640.
45. Bhat HF, Baba RA, Bashir M, et al., α-1-Syntrophin protein is differentially expressed in human cancers. Biomarkers 2011; 16: 31-36.
46. Schubert S, Knoch KP, Ouwendijk J, et al., β2-Syntrophin is a Cdk5 substrate that restrains the motility of insulin secretory granules. PLoS One 2010; 5: e12929-.
47. Furumai R, Uchida K, Komi Y, et al., Spliceostatin A blocks angiogenesis by inhibiting global gene expression including VEGF. Cancer Sci 2010; 101: 2483-2489.
48. Agromayor M, Carlton JG, Phelan JP, et al., Essential role of hIST1 in cytokinesis. Mol Biol Cell 2009; 20: 1374-1387.
49. Liang K, Lin Y, Zhang Y, et al., Developmental expression of Amphioxus GABAA receptor-associated protein-like 2 gene. Dev Genes Evol 2004; 214: 339-341. (Pubitemid 39157696)
50. Betin VM, Lane JD,. Caspase cleavage of Atg4D stimulates GABARAP-L1 processing and triggers mitochondrial targeting and apoptosis. J Cell Sci 2009; 122: 2554-2566.
51. Brandl K, Rutschmann S, Li X, et al., Enhanced sensitivity to DSS colitis caused by a hypomorphic Mbtps1 mutation disrupting the ATF6-driven unfolded protein response. Proc Natl Acad Sci USA 2009; 106: 3300-3305.
52. van Wezel T, Lombaerts M, van Roon EH, et al., Expression analysis of candidate breast tumour suppressor genes on chromosome 16q. Breast Cancer Res 2005; 7: R998-1004.
53. Hanahan D, Weinberg RA,. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674.
54. Santarosa M, Ashworth A,. Haploinsufficiency for tumour suppressor genes: when you don't need to go all the way. Biochim Biophys Acta 2004; 1654: 105-122. (Pubitemid 38681204)